Reversal of SARS-CoV2-Induced Hypoxia by Nebulized Sodium Ibuprofenate in a Compassionate Use Program

Autor: Lucia G. Guzmán, Celia S. Giler, Jorge L. Tambini Diaz, Germán D. Bueno, Marcelo Alejandro Beltrán, Leandro E. Peña Chiappero, Germán Ambasch, Javier A. Sala Mercado, Hernan A Perez, Carlos Martínez Picco, Néstor H. García, Daniela Josefina Porta, Galia I. Kalayan, Dario C. Quinodoz, Luis Alberto Argañarás, Esteban Coscia, Sonia E. Muñoz, Jorge O. Fandi, Pablo A. Doreski, Nicolás Martínez Ríos, Oscar Salva, Miriam A. Maldonado, Mauro A. Quiroga, Mariana N. Carrillo, Fernando Fournier, Dante M. Beltramo

Publikováno v: Infectious Diseases and Therapy
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET

Introduction: Sodium ibuprofenate in hypertonic saline (NaIHS) administered directly to the lungs by nebulization and inhalation has antibacterial and anti-inflammatory effects, with the potential to deliver these benefits to hypoxic patients. We des

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::147bea9990e111faeafbb16ce6279651
http://europepmc.org/articles/PMC8404026